Katerina Vlachopoulou

Katerina Vlachopoulou is an experienced professional in Health Economics and Outcomes Research (HEOR) with a diverse background in various roles across leading companies. Currently serving as the Global Lead for HEOR at Allergy Therapeutics since January 2022, Katerina develops and executes global HEOR strategies. Prior experience includes positions as Associate Director HEOR at Astellas Europe, Manager HEOR at Gilead Sciences, and Senior Analyst at Amaris, where Katerina led projects involving systematic literature reviews and HTA submissions. Early career roles include Health Economist and Research Associate at Symmetron Limited, along with a Quality Support Officer position at Barts and The London NHS Trust. Katerina holds a Master's degree in Health/Health Care Administration/Management from City, University of London and a Bachelor's degree in Economics from the University of Piraeus.